Saliva is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2

被引:26
|
作者
Callahan, Cody [1 ,2 ]
Ditelberg, Sarah [2 ]
Dutta, Sanjucta [2 ]
Littlehale, Nancy [4 ]
Cheng, Annie [2 ]
Kupczewski, Kristin [2 ]
McVay, Danielle [2 ]
Riedel, Stefan [2 ,4 ,5 ]
Kirby, James E. [2 ,4 ,5 ]
Arnaout, Ramy [2 ,3 ,4 ,5 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[3] Beth Israel Deaconess Med Ctr, Div Clin Informat, Dept Med, Boston, MA 02215 USA
[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[5] Harvard Med Sch, Boston, MA 02115 USA
来源
MICROBIOLOGY SPECTRUM | 2021年 / 9卷 / 01期
关键词
SARS-CoV-2; COVID-19; saliva; NP swab; limit of detection;
D O I
10.1128/Spectrum.00162-21
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The continued need for molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the potential for self-collected saliva as an alternative to nasopharyngeal (NP) swabs for sample acquisition led us to compare saliva to NP swabs in an outpatient setting without restrictions to avoid food, drink, smoking, or tooth-brushing. A total of 385 pairs of NP and saliva specimens were obtained, the majority from individuals presenting for initial evaluation, and were tested on two high-sensitivity reverse transcriptase PCR (RT-PCR) platforms, the Abbott m2000 and Abbott Alinity m (both with limits of detection OD] of 100 copies of viral RNA/ml). Concordance between saliva and NP swabs was excellent overall (Cohen's kappa = 0.93) for both initial and follow-up testing, for both platforms, and for specimens treated with guanidinium transport medium as preservative as well as for untreated saliva (kappa = 0.88 to 0.95). Viral loads were on average 16x higher in NP specimens than saliva specimens, suggesting that only the relatively small fraction of outpatients (similar to 8% in this study) who present with very low viral loads (<1,600 copies/ml from NP swabs) would be missed by testing saliva instead of NP swabs when using sensitive testing platforms. Special attention was necessary to ensure leak-resistant specimen collection and transport. The advantages of self-collection of saliva, without behavioral restrictions, will likely outweigh a minor potential decrease in clinical sensitivity in individuals less likely to pose an infectious risk to others for many real-world scenarios, especially for initial testing. IMPORTANCE In general, the most accurate COVID-19 testing is hands-on and uncomfortable, requiring trained staff and a "brain-tickling" nasopharyngeal swab. Saliva would be much easier on both fronts, since patients could collect it themselves, and it is after all just spit. However, despite much interest, it remains unclear how well saliva performs in real-world settings when just using it in place of an NP swab without elaborate or cumbersome restrictions about not eating/drinking before testing, etc. Also, almost all studies of COVID-19 testing, whether of NP swabs, saliva, or otherwise, have been restricted to reporting results in the abstruse units of "C-T values," which only mean something in the context of a specific assay and testing platform. Here, we compared saliva versus NP swabs in a real-world setting without restriction and report all results in natural units-the amount of virus being shed-showing that saliva is essentially just as good as NP swabs.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [41] Detection of SARS-CoV-2 RNA Using RT-qPCR in Saliva Samples and Nasopharyngeal, Lingual, and Buccal Mucosal Swabs
    Sasaki, Tomoyuki
    Inoue, Osamu
    Ogihara, Shinji
    Kubokawa, Kayo
    Oishi, Saori
    Shirai, Toshiaki
    Iwabuchi, Keisuke
    Suzuki-Inoue, Katsue
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2022, 75 (01) : 102 - 104
  • [42] Performance study of two rapid antigen detection methods in combined swabs and nasopharyngeal swabs for detection of SARS-CoV-2
    Zubieta, Martin
    Rahhal, Marilina
    Valdi, Elba Mercedes
    Diaz, Rosa Viviana
    Mendoza, Diana Elizabeth
    Romero, Sergio Ezequiel
    Martinez, Debora Magali Garcia
    Aranzetti, Sebastian Nicolas
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2021, 55 (04): : 485 - 489
  • [43] Evaluation of Sample Pooling for SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples with the Idylla SARS-CoV-2 Test
    Hofman, Paul
    Allegra, Maryline
    Salah, Myriam
    Benzaquen, Jonathan
    Tanga, Virginie
    Bordone, Olivier
    Fayada, Julien
    Long-Mira, Elodie
    Lassalle, Sandra
    Lanteri, Elisabeth
    Lespinet-Fabre, Virginie
    Brest, Patrick
    Mograbi, Baharia
    Maniel, Charlotte
    Boutros, Jacques
    Leroy, Sylvie
    Heeke, Simon
    Hofman, Veronique
    Marquette, Charles-Hugo
    Ilie, Marius
    MICROBIOLOGY SPECTRUM, 2021, 9 (03):
  • [44] Swish and gargle saliva sampling is a patient-friendly and comparable alternative to nasopharyngeal swabs to detect SARS-CoV-2 in outpatient settings for adults and children
    Isabel, Sandra
    Cohen-Silver, Justine
    Jung, Hyejung
    Tam, Bridget
    Lota, Maya
    Sivilotti, Marcia
    Agbaje, Nancy
    Schwartz, Kevin L.
    Wormsbecker, Anne E.
    Matukas, Larissa M.
    Chen, Yan
    MICROBIOLOGY SPECTRUM, 2023, 11 (06):
  • [45] Is Nasopharyngeal Swab Comparable With Nasopharyngeal Aspirate to Detect SARS-CoV-2 in Children?
    Capecchi, Ester
    Di Pietro, Giada Maria
    Luconi, Ester
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (09) : E288 - E289
  • [46] Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 Diagnosis
    Byrne, Rachel L.
    Kay, Grant A.
    Kontogianni, Konstantina
    Aljayyoussi, Ghaith
    Brown, Lottie
    Collins, Andrea M.
    Cuevas, Luis E.
    Ferreira, Daniela M.
    Fletcher, Tom
    Fraser, Alice J.
    Garrod, Gala
    Hill, Helen
    Hughes, Grant L.
    Menzies, Stefanie
    Mitsi, Elena
    Owen, Sophie I.
    Patterson, Edward I.
    Todd, Stacy
    Williams, Christopher T.
    Hyder-Wright, Angela
    Adams, Emily R.
    Cubas-Atienzar, Ana I.
    EMERGING INFECTIOUS DISEASES, 2020, 26 (11) : 2769 - 2770
  • [47] Letter in response to 'Saliva is inferior to nose and throat swabs for SARS-CoV-2 detection in children'
    Chu, Stephen
    Hale, Samuel
    ACTA PAEDIATRICA, 2021, 110 (12) : 3387 - 3387
  • [48] Assessment of Multiplex Digital Droplet RT-PCR as a Diagnostic Tool for SARS-CoV-2 Detection in Nasopharyngeal Swabs and Saliva Samples
    Cassinari, Kevin
    Alessandri-Gradt, Elodie
    Chambon, Pascal
    Charbonnier, Francoise
    Gracias, Segolene
    Beaussire, Ludivine
    Alexandre, Kevin
    Sarafan-Vasseur, Nasrin
    Houdayer, Claude
    Etienne, Manuel
    Caron, Francois
    Plantier, Jean Christophe
    Frebourg, Thierry
    CLINICAL CHEMISTRY, 2021, 67 (05) : 736 - 741
  • [49] Identification of SARS-CoV-2 in post-mortem nasopharyngeal swabs
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    FORENSIC SCIENCE INTERNATIONAL, 2021, 324
  • [50] Non-Invasive Detection of SARS-CoV-2 Antigen in Saliva versus Nasopharyngeal Swabs Using Nanobodies Conjugated Gold Nanoparticles
    Kamel, Manal
    Maher, Sara
    El-Baz, Hanan
    Salah, Faten
    Sayyouh, Omar
    Demerdash, Zeinab
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (06)